| Literature DB >> 35006439 |
Hiroshi Mitoma1, Jerome Honnorat2,3, Kazuhiko Yamaguchi4, Mario Manto5,6.
Abstract
There is general agreement that auto-antibodies against ion channels and synaptic machinery proteins can induce limbic encephalitis. In immune-mediated cerebellar ataxias (IMCAs), various synaptic proteins, such as GAD65, voltage-gated Ca channel (VGCC), metabotropic glutamate receptor type 1 (mGluR1), and glutamate receptor delta (GluR delta) are auto-immune targets. Among them, the pathophysiological mechanisms underlying anti-VGCC, anti-mGluR1, and anti-GluR delta antibodies remain unclear. Despite divergent auto-immune and clinical profiles, these subtypes show common clinical features of good prognosis with no or mild cerebellar atrophy in non-paraneoplastic syndrome. The favorable prognosis reflects functional cerebellar disorders without neuronal death. Interestingly, these autoantigens are all involved in molecular cascades for induction of long-term depression (LTD) of synaptic transmissions between parallel fibers (PFs) and Purkinje cells (PCs), a crucial mechanism of synaptic plasticity in the cerebellum. We suggest that anti-VGCC, anti-mGluR1, and anti-GluR delta Abs-associated cerebellar ataxias share one common pathophysiological mechanism: a deregulation in PF-PC LTD, which results in impairment of restoration or maintenance of the internal model and triggers cerebellar ataxias. The novel concept of LTDpathies could lead to improvements in clinical management and treatment of cerebellar patients who show these antibodies.Entities:
Keywords: Anti-GluR delta antibody; Anti-VGCC antibody; Anti-mGluR antibody; Cerebellar ataxias; Immune-mediated cerebellar ataxias; Long-term depression
Year: 2021 PMID: 35006439 PMCID: PMC8607360 DOI: 10.1186/s43556-020-00024-x
Source DB: PubMed Journal: Mol Biomed ISSN: 2662-8651
Fig. 1Schematic diagram of the pathophysiological mechanisms underlying anti-VGCC, anti-mGluR1, and anti-GluR delta-associated cerebellar ataxias. The antibody-mediated mechanisms include dysfunction of basal synaptic transmissions and long-term depression (LTD), leading to impairment of the internal model. These functional disorders are followed by cell-mediated cell death, depending on the auto-immune stimulus. PC; Purkinje cell, GC; granule cell, IN; inhibitory interneurons, CF; climbing fiber, PF; parallel fiber, MF; mossy fiber
Fig. 2Schematic diagram of long-term depression (LTD) at excitatory synapses between parallel fibers and Purkinje cells. The climbing fiber input elicits complex spikes through the activation of dendritic P/Q type Ca2+ channels, leading to an increase in intracellular calcium concentration ([Ca2+]i). On the other hand, the parallel fiber input activates metabotropic glutamate receptor-PLCβ-IP3 signaling pathways, resulting in an increase in [Ca2+]i. The conjunctive activation of these two pathways increases [Ca2+]i more than the additive level. The high [Ca2+]i activates PKCα, and PKCα phosphorylates GluA2 of the AMPA (α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) receptor, which results in detachment of the AMPA receptor from scaffold proteins and its internalization with PICK1 in an AP2 and clathrin-dependent manner. CF; climbing fibers, PF; parallel fibers, Glu; glutamate; AMAPA-R; AMPA receptor, mGluR1; metabotropic glutamate receptor, Cav2.1 (P/Q); P/Q type Ca2+ voltage-gated channel, PLC; phospholipase C, PKC; protein kinase C, IP3; Inositol triphosphate, GRIP; Glutamate receptor interactive protein, TARP; transmembrane AMPA receptor regulatory proteins, PICK1; protein interacting with C kinase, δ; GluR delta 2, PTPMEG; megakaryocyte protein phosphatase
Clinical profiles of anti-VGCC, anti-mGluR and GluR delta antibodies-associated cerebellar ataxias
| Anti-VGCC | Anti-mGluR1 | Anti-GluR delta | |
|---|---|---|---|
| Prevalence in IMCAs | Sometimes | Rare | Rare |
| Trigger of autoimmunity | Mainly with paraneoplasia (SCLS, prostate adenocarcinoma, non-Hodgkin’s lymphoma). A few without paraneoplasia | Some with paraneoplasia (Hodgkin’s lymphoma, prostate adenocarcinoma). Others without paraneoplasia and infection | Infection, vaccination |
| Age, gender | 50–60s | Median 55 years (IQR 43–64), 43% females | Children |
| Features of CAs | Pancerebellar ataxias | Gait and limb ataxias | Gait ataxia associated with limb ataxia and dysarthria |
| MRIa | Variable: From no to mild atrophy | No atrophy | |
| Outcomes | Paraneoplasia: Variable. From good to poor response to IVIg, prednisone and mycophenolate mofetil. Non-paraneoplasia: Improvement reported. | Paraneoplasia: Variable. From good response to poor response to IVIg, PE.. Non-paraneoplasia: Generally good response to IVIg, steroid, mycophenolate, and rituximab. | Generally good response to IVIg or IVMP. |
| Paraneoplasia, | Paraneoplasia /Non-paraneoplasia [ | Non-paraneoplasia, | |
| Full or partial recovery | 1 (10%) | 10 (40%) | 2 (67%) |
| Stabilization | 6 (55%) | 14 (56%) | 1 (33%) |
| Persistent aggravation | 5 (45%) | 1 (4%) | 0 |
IMCAs Immune-mediated cerebellar ataxias, SCLS Small cell lung cancer, IVIg Intravenous immunoglobulins, IVMP Intravenous methylprednisolone, PE Plasma exchange
Interpretation: the occurrence of cerebellar atrophy appears variable from case to case. The mechanisms of the atrophy remain to be discovered. This occurs also in other immune-mediated cerebellar ataxias